Fusion Pharmaceuticals a newly formed biopharmaceutical company developing targeted alphaparticle radiotherapeutics for treating cancer today announced the closing of a 25 million Series A financing led by founding venture investor Johnson Johnson Innovation JJDC Inc with investments by HealthCap ..
Acticor Biotech a biotechnology company focused on the treatment of acute ischemic stroke today announced that it selected its CRO Contract Research Organization to manage its clinical study phase I The firstinhuman study with ACT017 will be conducted at QPS facilities in Groningen the Netherland..
PMV Pharmaceuticals Inc a leader in the discovery and development of p53targeted small molecule drugs for the treatment of cancer today announced the completion of a 74 million Series B financing round This financing was led by Topspin Biotech Fund and a group of investors with Euclidean Capital wit..
Lannett Company Inc announced that it was notified by US Food and Drug Administration FDA late yesterday afternoon that FDA suspended indefinitely the deadline for the Company to submit materials in support of its request for a hearing to consider FDA39s proposal that Lannett withdraw its Abbreviate..
Envigo is pleased to announce that it has developed and validated a robust analytical method to evaluate the potential effects on thyroid hormone levels in rat F1 offspring It is now possible for Envigo to successfully determine levels of T3 triiodothyronine and T4 thyroxine hormones in serum from r..
Lysogene a leading clinicalstage biotechnology company specializing in gene therapy for rare central nervous system diseases today announces that the European Medicines Agency EMA has granted orphan drug designation to LYSGM101 the Companys gene therapy drug candidate for treatment of GM1 Gangliosid..
Eagle Pharmaceuticals Inc announced that four additional patents have been issued related to Bendeka by the United States Patent and Trademark Office USPTO Patent numbers 9572796 and 9572797 will expire January 2031 Patent numbers 9572887 and 9572888 will expire March 2033 The US Patent and Trademar..
CohBar Inc a preclinical stage biotechnology company focused on developing mitochondria based therapeutics MBTs to treat agerelated diseases announced today that it has completed a study to evaluate the potential efficacy of its lead drug candidates MOTSc peptide analogs CB4209 and CB4211 in a welle..
Immuron Limited an Australian biopharmaceutical company focused on oral immunotherapy utilizing polyclonal antibody products to target immunemediated diseases today announced that the Companys IMM124E Phase II clinical trial for the treatment of NASH NonAlcoholic Steatohepatitis has successfully rea..
Karolinska Development AB announces its portfolio company Modus Therapeutics AB a company focused on innovative treatments for patients with sickle cell disease has successfully completed a financing round raising SEK 32 million USD 36 million from existing investors KDev Investments stersjstiftelse..
Exelixis Inctoday announced results from a phase 1 trial of cabozantinib in combination with either nivolumab or nivolumab plus ipilimumab in patients with refractory genitourinary tumors The primary endpoint of the trial is to determine the dose limiting toxicity DLT and recommended phase 2 doses o..
AstraZeneca today announced positive results from its Phase III OlympiAD trial comparing LYNPARZA olaparib tablets 300mg twice daily to physicians choice of a standard of care chemotherapy in the treatment of patients with HER2negative metastatic breast cancer harboring germline BRCA1 or BRCA2 mutat..
CPhI Russia IPhEB cphirussia returns to the Russian capital taking place at the JSC VDNH VVC Moscow 28th30th March as the Governments Pharma 2020 plan continues to stimulate demand for international pharmaceutical ingredients manufacturing and packaging equipment The events 4th edition will see th..
Innovations and Advancements in Drug Discovery Changing the Topography of Pharmaceutical Industry Rapidly The demand for drug discovery technologies in the region of North America also gains from highincome population collectively promising healthy potential returns on investments due to high ado..
Boehringer Ingelheim today announced that the US Food and Drug Administration FDA approved tiotropium Respimat marketed as SPIRIVA Respimat for the longterm oncedaily maintenance treatment of people with asthma aged 6 years and older who continue to experience symptoms despite their other maintenanc..
Ascendis Pharma AS a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases today announced the publication of its previously presented pediatric phase 2 trial of TransCon Growth Hormone in the Journal of Clinical Endocr..
Ionis Pharmaceuticals Incand Akcea Therapeutics a whollyowned subsidiary of Ionis Pharmaceuticals Inc announced today they have closed on their exclusive worldwide option and collaboration agreement with Novartis to develop and commercialize AKCEAAPOaLRx and AKCEAAPOCIIILRx following clearance under..
Clintec today announces the launch of its new brand identity reflected in their newly created website This in part marks Clintecs 20th anniversary and the achievement of significant milestones following another year of substantial growth together with a succession of key appointments that have enha..
Pharmapack Europe organised by UBM EMEA closed its 2017 edition celebrating its 20 years as the leading European event for pharmaceutical packaging and drug delivery devices The top trends that emerged from the twoday event included patient centricity traceability innovation compliance and adheren..
In a report published today in Nature Sterile protection against human malaria by chemoattenuated PfSPZ vaccine investigators from the University of Tbingen reported all nine subjects 100 immunized with three doses of Sanaria PfSPZCVac malaria vaccine in a recently completed clinical trial were prot..